Clinical Trial Update: DNA Vaccine for Ragweed Allergic Adults [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for a DNA vaccine in adults with seasonal allergic rhinitis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Seasonal Allergic Rhinitis

Drugs mentioned

• DNA vaccine for ragweed allergic adults

Snippet

Sponsor: Johns Hopkins University | Conditions: Seasonal Allergic Rhinitis | Phase 2 | Status: COMPLETED